CSX
54
4
COF
65
2
SLB
44
5
NWL
61
3
PYPL
50
-4
NOV
58
5
CHD
34
2
KR
49
-3
LH
53
-2
GS
72
2
HRL
47
2
BXP
46
-3
OI
50
-5
SYY
53
-3
MO
54
-3
TMO
60
2
VZ
54
2
PNC
75
6
EW
55
-2
FIS
58
-2
CSX
54
4
COF
65
2
SLB
44
5
NWL
61
3
PYPL
50
-4
NOV
58
5
CHD
34
2
KR
49
-3
LH
53
-2
GS
72
2
HRL
47
2
BXP
46
-3
OI
50
-5
SYY
53
-3
MO
54
-3
TMO
60
2
VZ
54
2
PNC
75
6
EW
55
-2
FIS
58
-2
Financhill
Back

Catalyst Pharmaceuticals, Inc. 10K Form

Buy
67

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$23.08
Seasonality Move:
1.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $491.7M
Cash Flow: $32.4M
Price / Cash Flow: 12.51
Annual Sales: $7.47
Price / Book: 3.09

Profitability

EPS (TTM): 1.71380
Net Income (TTM): $217.6M
Gross Margin: $385.5M
Return on Equity: 27.48%
Return on Assets: 23.86%

Catalyst Pharmaceuticals, Inc. Earnings Forecast

Key Catalyst Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 23 years for CPRX is 78.40%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 31.98% of Gross Profit Margin.
  • The Research & Development expenses have been 2.57% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CPRX is 33.33% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Catalyst Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.62
Quick Ratio: 6.19

Price-to-Earnings

Trailing P/E Ratio: 17.61
Forward P/E Ratio: 8.94

CPRX Technical Analysis vs Fundamental Analysis

Buy
67
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. a Buy or a Sell?